Log In
Print
BCIQ
Print
Print this Print this
 

PEG-SN38 (firtecan pegol) (BEL-0222) (formerly EZN-2208)

  Manage Alerts
Collapse Summary General Information
Company Belrose Pharma Inc.
DescriptionPegylated form of SN38, the active metabolite of irinotecan
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today